| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |